Low-Temperature Plasma ENT Probe for Tonsillectomy | Precise Tissue Ablation and Minimal Bleeding

The Low-Temperature Plasma ENT Probe revolutionizes tonsillectomy procedures by delivering controlled plasma energy at 40-70°C, significantly reducing thermal damage compared to traditional electrosurgery. As a next-generation ENT probe, its pulsed ablation mode enables layer-by-layer tissue removal with 0.3mm precision, allowing surgeons to preserve healthy mucosa while achieving hemostasis within 2 seconds.

ENT Plasma Surgical probe Features

Advanatages

Clinically validated across 12 medical centers, this ENT surgical probe reduces postoperative pain scores by 62% (p<0.01) and bleeding complications by 78% in pediatric adenotonsillectomy cases. The ergonomic handpiece integrates smart pressure sensors that automatically modulate energy output when contacting lymphoid tissue, making this plasma ENT device indispensable for day-case ENT surgeries.

CE/FDA-cleared ENT probe comes with 18-month warranty and onsite sterilization training. Probes are compatible with all major plasma generators through our universal adapter system (sold separately).

• In cases of chronic tonsillitis with recurrent and severe acute flare-ups, where the frequency and intensity of the attacks pose a significant threat to the patient's well-being and quality of life.
• When there is a documented history of abscess formation in the vicinity of the tonsils, which may lead to potential complications and recurrent infections if not addressed.
• For patients experiencing extreme hypertrophy of the tonsils to such an extent that it causes obstruction during swallowing or breathing, or when it disrupts the normal function of the eustachian tube, thereby affecting hearing and ear health.
• In situations where the tonsils exhibit simple III degree enlargement or are very close to III degree hypertrophy, which can have an impact on the normal physiological functions in the oral and pharyngeal regions.
• Among patients diagnosed with rheumatic fever, nephritis, arthritis, or rheumatic heart disease, and there is a suspicion that the tonsils might be the source or contributing factor to the underlying pathological condition.
• In the presence of benign tumors originating from the tonsils, which require appropriate medical intervention to manage and prevent potential growth and associated issues.